Yahoo Finance

Investment in Women's Health reached $2.6 billion in 2024 despite challenging fundraising environment

SAN FRANCISCO, April 2, 2025 /PRNewswire/ -- Venture capital investment in women's health startups has experienced significant growth in recent years, with funding reaching new heights in 2024. According to the latest report from Silicon Valley Bank (SVB), a division of First Citizens Bank, women's health investment hit $2.6 billion last year, surpassing 2023's total by nearly $1 billion. When including funding for related diseases that affect women differently or disproportionately, total investment in the sector rose to $10.7 billion.

Leveraging SVB's proprietary data and analysis, the 2025 Innovation in Women's Health Report explores the current fundraising landscape, key trends, and emerging innovations across the sector.

"Investment in women's health continues to reach new milestones, driven by a growing recognition of the ways in which health conditions impact women differently," said Raysa Bousleiman, co-author of the report and senior vice president for Investor Coverage in Life Science and Healthcare at SVB. "While 2025 may present challenges, the long-term potential of the sector is clear, and we expect continued investment focused on addressing the unmet healthcare needs for women."

Key findings from the Innovation in Women's Health Report include:

• Increased awareness is fueling investment: Investment in women's health has grown significantly. In 2024, the sector saw a 55% increase in VC investment, outpacing growth in the broader healthcare industry.

• Sector innovation follows broader healthcare trends: As the women's health sector evolves, it is increasingly diversified, following in the footsteps of the wider healthcare industry. Investment in healthtech solutions dropped from 54% in 2021 to 38% in 2024, while biopharma investment surged to 34%, up from just 12% in 2021.

• Women's health investment stages now mirror the larger healthcare sector: In 2023, seed and Series A deals made up 83% of women's health investments, compared to 72% in the overall healthcare space. The gap narrowed in 2024, with seed and Series A deals representing 70% and 67%, respectively, of total deals in each sector.

• Precision medicine and personalized health are taking center stage: Funding flooded into early-stage startups focused on filling gaps in clinical pathway guidelines for women's health. In 2024, VC investment in precision medical startups totaled $3.6 billion, up from $1.4 billion in 2023.

• Exits remain a challenge but potential is growing: The lack of exits in women's health has raised concerns about the sector's potential, with investors noting difficulty in finding comparable companies and doubts about large returns. However, recent IPOs and M&A activity in related areas suggest that women's health could help break the exit logjam in the broader healthcare market.